First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO)

Oncology (Switzerland)

Volumn 54, Issue 5, 1997, Pages 371-375

  Samonis, George ^a   Bafaloukos, D ^b   Margioris, A N ^a   Katsarma, G ^b   Toloudis, P ^a   Bacoyannis, C ^b   Karvounis, N ^b   Georgoulias, V ^a   Kosmidis, P ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b Metaxa s Cancer Institute of Piraeus   (Greece)

Author keywords

Breast cancer; Carboplatin; Chemotherapy; Methotrexate; Mitoxantrone; Vincristine

Indexed keywords

CARBOPLATIN; METHOTREXATE; MITOXANTRONE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; BREAST CANCER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIARRHEA; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; PRIORITY JOURNAL; STOMATITIS; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BREAST NEOPLASMS; CARBOPLATIN; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; NAUSEA; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE;

EID: 0030761978     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227721     Document Type: Article

References (15)

1. Harris JR, Morrow M, Bonadonna G: Cancer of the breast; in De Vita VT, Heilman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology, ed 4. Philadelphia, Lip-pincott, 1993, pp 1264-1325.
2. Bafaloukos D, Samonis G, Klinaki A, Daliani D, Karvounis N, Bacoyannis C, Karabelis A, Milonakis N, Kosmidis P: First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer. Eur J Cancer 1993; 29A:851-853.
3. Bafaloukos D: Platinum derivatives in bladder cancer; in Platinum Derivatives. Athens, European School of Oncology, 1991. pp 286-298.
4. Hayward JL, Carbonne PP, Heuson JC, Ku-maoka S, Segaloff A, Reubens RD: Assessment of response to therapy in advanced breast cancer. Cancer 1977;9:1289-1294.
5. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, World Health Organization, 1979, WHO offset publication No 48.
6. Kaufmann M, Manegold C, Schmid H, Kubli F: Phase II study of mitoxantrone and predni-mustine in advanced breast cancer, in Bonadonna G (ed): Clinical Progress with Mitoxantrone. R Soc Med Serv Int Congr Symp Ser 1987;110:17-25.
7. Holmes FA, Yap HY, Esparga M: Mitoxantrone, cyclophosphamide and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy. Cancer 1987;59:1992-1996.
8. Berwoda WR, Hesdorffer CS: Mitoxantrone. methotrexate and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer. Cancer 1986;57:218-222.
9. Trudeau ME: Docetaxcl (Taxotere): An overview of first-line monotherapy. Semin Oncol 1995:22:17-21.
10. Greenberg PAC, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU: Long term follow up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 1996:14: 2197-2205.
11. Smith G, Henderson IC: New treatment for breast cancer. Semin Oncol 1996:33:506-528.
12. Gianni L, Munzone E, Capri G, Fulfaro F, Tar-enzi E, Villani F, Spreafico C, Laffranchi A, Caraccni A, Martini C, Stefanelli M, Vilagussa P, Bonadonna G: Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 1995;13:2688-2699.
13. Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Franschini G, Buzdar AU, Frye D, Gibbs HR, Hortobagyi GN: The MD Anderson Cancer Center experience with taxol in metastatic breast cancer. Monogr Natl Cancer Inst 1993;15:161-169.
14. Martin M, Diaz-Rubio E, Casado A, Lopez-Vega JM: Phase II study of carboplatin in advanced breast cancer. Semin Oncol 1991; 18: 23-27.
15. Smith IE: Platinum derivatives in breast cancer; in Platinum Derivatives. Athens, European School of Oncology, 1991, pp 238-249.